covid 19 News and Research

RSS

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Researchers evaluated COVID-19 monoclonal antibody treatment in pregnant and postpartum women.

16 Mar 2022

Prolonged unconsciousness is common in COVID-19 patients, recovery often takes days or even weeks

During the first wave of the COVID-19 pandemic, many patients in intensive care units did not recover consciousness after their breathing tubes were removed and their sedation was stopped, leaving clinicians and families with difficult decisions about whether to continue life-sustaining therapy.

16 Mar 2022

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

Researchers identified curcumin derivatives as potential inhibitors of SARS-CoV-2 enzymes.

16 Mar 2022

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

We speak to Dr. Alemnew Dagnew from the Bill & Melinda Gates Medical Research Institute, about their tuberculosis vaccine study and the future of tuberculosis.

16 Mar 2022

Novel targets to inhibit SARS-CoV-2 variants

A new study identified additional targets on SARS-CoV-2 proteins to prevent the emergence of new SARS-CoV-2 variants of concern.

16 Mar 2022

Estimating SARS-CoV-2 breakthrough infection numbers in the US

A new study estimated the number of symptomatic COVID-19 breakthrough infections in vaccinated individuals in the US.

16 Mar 2022

Convalescent antibodies do not enhance SARS-CoV-2 infection

Researchers investigated whether antibodies enhance severe acute respiratory syndrome coronavirus-2 infection.

16 Mar 2022

Doctors and nurses highlight what is needed to fill gaps and future-proof the healthcare system

Thousands of doctors and nurses from across the globe reveal what is needed to fill gaps and future-proof today’s healthcare system in a new report from Elsevier Health, published two years after the COVID-19 pandemic began.

16 Mar 2022

Roche launched world's first COVID-19 PCR test two years ago

In the two years since it launched the world's first commercially available COVID-19 PCR test, Roche Diagnostics UK and Ireland has distributed ten million tests from its base in West Sussex.

From Roche Sequencing and Life Science 16 Mar 2022

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

Since the very beginning of the pandemic, there has been concern about the emergence of Guillain-Barré syndrome, a rare disorder where the body's immune system damages nerves. In some cases, nerve damage causes muscle weakness and paralysis.

16 Mar 2022

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A considerably high prevalence of COVID-19 has been observed among study participants. The study is currently available on the Research Square* Preprint Server.

16 Mar 2022

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

In a recent research paper currently available on bioRxiv* preprint server, scientists from the University of Oxford in the United Kingdom and the University of Auckland in New Zealand identified several structural specificities of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that may serve as viable starting points for the development and optimization of viral inhibitors against coronavirus disease 2019 (COVID-19) and other future threats.

16 Mar 2022

covid 19 News and Research

Study evaluates monoclonal antibody treatment for pregnant COVID-19 patients

Prolonged unconsciousness is common in COVID-19 patients, recovery often takes days or even weeks

In silico identification of novel curcumin derivatives as potential inhibitors against SARS-CoV-2 enzymes

The Future of Tuberculosis; An Interview with the Bill & Melinda Gates Medical Research Institute

Novel targets to inhibit SARS-CoV-2 variants

Estimating SARS-CoV-2 breakthrough infection numbers in the US

Convalescent antibodies do not enhance SARS-CoV-2 infection

Doctors and nurses highlight what is needed to fill gaps and future-proof the healthcare system

Roche launched world's first COVID-19 PCR test two years ago

Bibliographic review evaluates risk of Guillain-Barré syndrome after receiving COVID vaccination

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

New insight into SARS-CoV-2 nsp14 protein opens door to new drugs

Within-host mathematical model provides insight into dynamics of SARS-CoV-2 infection

Can cardiac biomarkers determine COVID-19 prognosis?

Good glycemic control in SARS-CoV-2 vaccinated type 2 diabetic patients reduces risk of breakthrough infection

Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Serious COVID-19 linked to higher risk of long-term adverse mental health effects

How capable are children to self-swab for SARS-CoV-2?

Researchers investigate loss of fitness following COVID-19

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News